Daily BriefsIndia

India: Mindtree Ltd, Aurobindo Pharma, Kajaria Ceramics and more

In today’s briefing:

  • S&P BSE Indices (SENSEX Family): Quiddity Leaderboard for June 2022 Rebalance
  • Aurobindo-Veritaz Acquisition: No Justice
  • Channel Insight #30 – Kajaria, Indigo Paints, Finolex Pipes

S&P BSE Indices (SENSEX Family): Quiddity Leaderboard for June 2022 Rebalance

By Janaghan Jeyakumar, CFA

  • The S&P BSE family of indices represents the performance of stocks listed on the Bombay Stock Exchange (BSE) across various sizes, themes, industries, and strategies.
  • This series will mainly focus on the following indices of the S&P BSE family: S&P BSE 500, S&P BSE 200, S&P BSE 100, and S&P BSE SENSEX.
  • In this insight, we take a look at the leading candidates who could become Adds/Deletes during the June 2022 Semi-annual Rebalance.

Aurobindo-Veritaz Acquisition: No Justice

By Nitin Mangal

  • On Monday, Aurobindo Pharma (ARBP IN) had announced the acquisition of the branded generic business and certain assets of Veritaz Healthcare Limited for a cash consideration of INR 1.7 bn.
  • It should be known that Veritaz is a promoter group entity, which is why acquisition will fall within the scope of Related Party Transactions.
  • Being a promoter company and having had some red flags in the past such as negative net-worth, continuous loss making nature, etc. The cash consideration looks questionable.

Channel Insight #30 – Kajaria, Indigo Paints, Finolex Pipes

By Pranav Bhavsar


Before it’s here, it’s on Smartkarma